The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and ...

Autosomal dominant tubulointerstitial kidney disease, better known as ADTKD, is a group of kidney disorders which are inherited. Sheri and David Dafoe have first-hand knowledge ...

Investigators estimated the burden and temporal trends of anemia of chronic kidney disease (CKD) at global, regional, and national levels.

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Immunoglobulin A nephropathy (IgAN), or Berger’s disease, is a chronic kidney disorder characterized by deposition of IgA antibodies in the glomeruli, which leads to inflammation and progressive renal ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

About Parkinson’s disease associated with GBA mutations (PD-GBA) Mutations in GBA, the gene expressing the GCase enzyme, affect up to 15% of Parkinson’s patients and are the most common ...

Capsida Biotherapeutics (“Capsida”) today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for CAP-003, its potential best-in ...

Unicycive Therapeutics shares lost nearly a third of their value on Tuesday after the clinical-stage biotechnology company said its bid to win U.S. Food and Drug Administration approval for its ...

BOSTON, June 10, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the U.S. Food and ...